AI Article Synopsis

  • Epiregulin is a member of the epidermal growth factor family that promotes proliferation and migration in renal proximal tubular cells (RPTC) in primary culture.
  • It was found to be as effective as EGF in enhancing these cellular processes by activating the EGF receptor (EGFR) and key signaling pathways (PI3K/Akt and ERK1/2).
  • Inhibition of EGFR and PI3K significantly reduced epiregulin's effects, indicating that it plays a crucial role in renal regeneration through its action on specific signaling pathways.

Article Abstract

Epiregulin is an epidermal growth factor (EGF) member that activates ErBB1 and ErBB4 homodimers and all possible heterodimeric ErbB complexes. Because its role in renal cell regeneration has not been investigated, we assessed the effect of exogenous epiregulin on regeneration of renal proximal tubular cells (RPTC) in primary culture. Epiregulin (10 ng/ml) was equivalent to EGF (10 ng/ml) in enhancing RPTC proliferation and migration. Epiregulin induced activation of the EGF receptor (EGFR), Akt, a downstream kinase of phosphoinositide 3-kinase (PI3K), and extracellular signaling-regulated kinase 1/2 (ERK1/2). Treatment with AG1478, a specific EGFR inhibitor, blocked phosphorylation of EGFR, Akt, ERK1/2, proliferation, and migration. Furthermore, inactivation of PI3K with LY-294002 blocked epiregulin-induced RPTC proliferation and, to a lesser extent, migration. However, blockade of ERK1/2 had no such effects. We suggest that epiregulin is a potent mitogen for renal epithelial cells and may contribute to renal regeneration through activation of EGFR and PI3/Akt pathways.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00082.2007DOI Listing

Publication Analysis

Top Keywords

proliferation migration
12
renal proximal
8
proximal tubular
8
tubular cells
8
rptc proliferation
8
egfr akt
8
epiregulin
6
renal
5
epiregulin promotes
4
proliferation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!